Skip to Main content Skip to Navigation
Journal articles

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

Abstract : Background: The purpose of this study was to determine the prognostic role of hormone receptor (HR) on inflammatory breast cancer (IBC) to elucidate its aggressive biological behavior. Methods: We evaluated the expression of estrogen receptor (ER) and progesterone receptor (PR) by immunohistochemical staining and determined the predictive and prognostic role of HR expression on 189 patients with HR+/HER2- IBC and 677 patients with HR+/HER2- stage III non-IBC. Furthermore, we performed gene expression (GE) analyses on 137 patients with HR+/HER2- IBC and 252 patients with HR+/HER2- non-IBC to detect genes that are specifically overexpressed in IBC. Results: The expression of ER% was significantly associated with longer distant disease-free survival and overall survival. However, there was no significant relationship between ER% and neoadjuvant chemotherapy outcome. In the GE study, 84 genes were identified as significantly distinguishing HR+ IBC from non-IBC. Among the top 15 canonical pathways expressed in IBC, the ERK/MAPK, PDGF, insulin receptor, and IL-7 signaling pathways were associated with the ER signaling pathway. Upregulation of the MYC gene was observed in three of these four pathways. Furthermore, HR+/HER2- IBC had significantly higher MYC amplification, and the genetic alteration was associated with poor survival outcome. Conclusions: Higher ER expression was significantly associated with improved survival in both HR+/HER2- IBC and HR+/HER2- stage III non-IBC patients. HR+/HER2- IBC had several activated pathways with MYC upregulation, and the genetic alteration was associated with poor survival outcome. The results indicate that MYC may be a key gene for understanding the biology of HR+/HER2- IBC.
Complete list of metadata

Cited literature [29 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02913696
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Monday, August 10, 2020 - 11:34:52 AM
Last modification on : Wednesday, October 27, 2021 - 7:20:38 AM
Long-term archiving on: : Monday, November 30, 2020 - 5:14:27 PM

File

s12885-020-06940-z.pdf
Publication funded by an institution

Identifiers

Collections

`

Citation

Toshiaki Iwase, Kenichi Harano, Hiroko Masuda, Kumiko Kida, Kenneth Hess, et al.. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer, BioMed Central, 2020, 20 (1), pp.430. ⟨10.1186/s12885-020-06940-z⟩. ⟨inserm-02913696⟩

Share

Metrics

Record views

158

Files downloads

282